TyraTech
<< < > >>
Search:
 
| Full PDF report | Print this page |
Annual Report & Accounts 2010 - Directors' Remuneration Report
slide
<< < > >>
Directors' Remuneration Report (CON TINUE D) Pension and Ot her Benefit s Executive Directors' basic salaries are set at levels which are deemed to include adequate provision for pension contributions. Each Executive Director is free to determine the amount of pension contribution payable from salary, given the age of the relevant Director and other personal circumstances. Executive Directors are entitled to make contributions from salary into the Group's 401(k) (see Directors' Pension Arrangements below). The Group funds the provision of private medical insurance cover for Executive Directors and their immediate family and Executive Directors participate in the Group's life insurance scheme, which has a lump sum payment in the event of death in service. Executi ve Dir ectors' Service Contr acts Dr. Armstrong entered into a service agreement with the Group, the principal terms of which were that if the Group terminated his employment, other than for good cause, the Group would pay to him the amount outstanding up to the date of the termination. In addition, if Dr. Armstrong's employment was terminated by the Group without good cause or if he resigned with good reason, the Group would pay an amount equal to the eighteen months' base salary and bonus, as well as accelerating the vesting of shares which would become free of re-purchase obligations in the current and subsequent year after the date of termination. On 4 January 2010 Dr. Armstrong resigned and received a termination payment of US $547,500 payable through March 2011. In addition, as a result of Dr. Armstrong's resignation, the Group accelerated the vesting of the final 25% of the original stock grant of 602,561 shares (150,403 shares) and re-priced the stock compensation expense from US $9.28 per share to US $0.15 per share, the share price at Dr. Armstrong's termination date. Kerdos Corporate Finance Limited (KC FL) entered into a consultant agreement for the services of Mr. Bigsby as the Chief Financial Officer of the Group. Mr. Bigsby was entitled to participate in the 2010 Bonus Plan while engaged by the Group. The contract was terminated on 4 August 2010 with the resignation of Mr. Bigsby. Mr. Reade entered into an employment agreement with the Company on 16 May 2010, the principle terms of which are that if the Company terminates his employment, other than for good cause, or if he resigns with good reason, he will be eligible, but not entitled to a sum equal to his annual base salary and bonus, as well as accelerating the vesting of shares which would become free of re-purchase obligations for the complete year after the date of termination. Mr. Reade may terminate the employment agreement on six months written notice. Non-executi ve Dir ectors' Lett ers of App ointment Dr. Vernon, Mr. Reade, Mr. Riley and Dr. Noonan entered into agreements with the Group on 25 May 2007, which govern the terms and conditions of their appointment as Nonexecutive Directors of the Group. Each appointment was for an initial term expiring upon conclusion of the next annual general meeting of the Group unless renewed at the end of that period for a further 12 month period. Dr. Vernon was entitled to fees totaling £47,500 for the year payable to Ziggus Holding Limited, of which Dr. Vernon is an employee. Mr. Reade was entitled to fees totaling £35,000 for the year payable to Global Strategy Expression Limited of which Mr. Reade is an employee. This fee arrangement with Mr. Reade was terminated when he assumed the Executive Chairman post. Dr. Noonan was entitled to fees totaling £32,500 for the year payable to T. K. Advisory Limited of which Dr. Noonan is an employee. Mr. Riley was entitled to fees of £35,000 for the year payable directly. Mr. Regan was appointed as a representative of Laurus/Valens and received no fees during the year. Mr. Hills entered into an agreement with the Group on 9 July 2010 which governs his term and conditions of his appointment as a Non-executive Director of the Group. This appointment is for an initial term expiring upon conclusion of the next annual general meeting of the Group unless renewed at the end of that period for a further 12 month period. Mr. Hills is entitled to fees totaling US $55,000 per year. In addition to fees, the Company reimburses the independent Non-E xecutive Directors for all reasonable out-of-pocket expenses incurred. 24